Sumary of Top in hem/onc: Pay gap in academic medicine, FDA approvals for GI cancers:
- Back to Healio A first-ever nationwide analysis of full-time academic medicine faculty revealed disparities in pay for men and women and across ethnicities and races, with women earning less than men regardless of race and ethnicity.
- Source: Adobe Stock Another top story highlighted a presentation at the Chemotherapy Foundation Symposium on recent treatment advancements in GI cancers, including the FDA approvals of immunotherapies such as nivolumab (Opdivo, Bristol Myers Squibb) and pembrolizumab (Keytruda, Merck).
- Read these and more top stories in hematology/oncology below: Report highlights wide pay gap for women, minorities in medicine The Association of American Medical Colleges, or AAMC, recently published the first-ever, national-level analysis of full-time faculty salaries in academic medicine by gender, race and ethnicity.
- FDA approvals in gastrointestinal cancers spark excitement in field FDA approvals of immunotherapies are among several exciting developments during the past couple of years in the field of upper GI cancers, according to a speaker at Chemotherapy Foundation Symposium.
- Lack of insurance ’completely’ accounts for lower cancer screening rates among unemployed Unemployment appeared to be associated with a lower likelihood of having health insurance and of being up to date on cancer screening tests, according to results of a study published in Cancer.
- New-onset diabetes provides ‘window of opportunity’ for early pancreatic cancer detection Pancreatic cancer often is called the silent killer.